Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 7,100 shares, a drop of 49.3% from the February 13th total of 14,000 shares. Based on an average trading volume of 53,200 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the company are sold short.
Lonza Group Stock Up 1.9 %
LZAGY traded up $1.15 during midday trading on Friday, hitting $62.13. 35,989 shares of the company were exchanged, compared to its average volume of 56,507. The company’s 50 day simple moving average is $63.66 and its 200 day simple moving average is $62.34. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.52 and a quick ratio of 1.38. Lonza Group has a 1-year low of $52.23 and a 1-year high of $68.29.
Analyst Upgrades and Downgrades
Separately, Redburn Atlantic raised Lonza Group to a “strong-buy” rating in a research report on Wednesday, November 27th.
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Further Reading
- Five stocks we like better than Lonza Group
- Top Stocks Investing in 5G Technology
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- 3 Best Fintech Stocks for a Portfolio Boost
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.